Environmental, Social And Governance Report

Overview

The report describes Viva Biotech's 2020 performance, including revenue of RMB697.0 million and continued expansion through the integration of Langhua Pharmaceutical. It establishes the year's ESG governance focus through an ESG working group approved by the Board and details measures covering cleaner production, resource management, employee safety, and community welfare. The Group reported 1,619 employees at year-end, including 643 newly consolidated from Langhua Pharmaceutical.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020
Period: 1 January 2020 – 31 December 2020
Publication date: 14 July 2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis
Matrix

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services